Results 221 to 230 of about 2,868,920 (272)

Better 10‐Year Cerebrovascular Outcome After Transplant Than on Standard‐Care in Sickle Cell Anemia: DREPAGREFFE Trial

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Management of cerebral vasculopathy in sickle cell anemia (SCA) includes standard‐care, that is, chronic transfusion (CT) or hydroxyurea, and hematopoietic cell transplantation (HCT). DREPAGREFFE‐1 (December 2010/June 2013), a French multicenter trial, was the first prospective trial comparing standard‐care to match sibling donor (MSD)‐HCT in ...
Francoise Bernaudin   +40 more
wiley   +1 more source

Editorial Note

Natural Language and Linguistic Theory, 2004
exaly   +3 more sources

Editorial Note

Gerontology & Geriatrics Education, 1996
Mats Viberg, Petre Stoica
openaire   +3 more sources

Home - About - Disclaimer - Privacy